Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogeneic adipose tissue-derived mesenchymal stromal cells in epidermolysis bullosa (Phase I/II)
2024-516614-37-00Phase 2Completed
- Sponsor
- Masaryk University
- Start
- Nov 2024
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2 trial of allogeneic adipose tissue-derived mesenchymal stromal cells in epidermolysis bullosa (EB) (2 arms), sponsored by Masaryk University. Primary endpoint: Incidence of adverse events of special interest (AESI). Started Nov 2024; status: completed.
02
Drugs
allogeneic adipose tissue-derived mesenchymal stromal cells
03
Conditions
epidermolysis bullosa (EB)
Beyond the preview
Go deeper on 2024-516614-37-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-516614-37-00.